metaLead Therapeutics

HOME - metaLead

Basel, Switzerland · Founded 2023 · $1.1M raised

Headquarters
Basel
Employees
1–10
Founded
2023
Business Model
B2B
Total Funding
$1.1M
Last Round
$1.1M SeedMay 2025
Rounds
1

About

metaLead Therapeutics is a University of Zurich spin-off developing metal-binding medicines for metal-related diseases. Its peptide-based platform is intended to improve on existing chelation therapies by selectively capturing toxic or misregulated metals while preserving essential metals. The company’s preclinical programs include treatments for Wilson disease and lead poisoning, with an emphasis on orally available candidates designed to improve efficacy, selectivity, and patient-friendly administration.

Summary

metaLead Therapeutics is a Biotech company based in Basel, Switzerland, founded in 2023. It has raised $1.1M in total across 1 round, most recently a $1.1M Seed round in May 2025.

Tech & App Stack

4 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

SeedSeed RoundMay 2025
$1.1M

Similar Companies

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

metaLead Therapeutics on Indexed.vc
<a href="https://indexed.vc/companies/metalead-therapeutics"><img src="https://indexed.vc/api/badge/company/metalead-therapeutics" alt="metaLead Therapeutics on Indexed.vc" width="260" height="76" /></a>